Archive - June 2022
Amarin’s Vazkepa secures NICE recommendation
First patient dosed in Scancell’s clinical trial for multiple cancers
High Fructose Consumption Linked To Liver Disease
FDA Approves Lilly and Incyte’s Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata
FDA Approves Amvuttra (vutrisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
Verona Pharma’s ensifentrine heads for phase 3 chronic obstructive pulmonary disease trial
Ziphius Vaccines and University of Antwerp begin collaboration
GSK unveils its brand identity as it demerges from Haleon